BioMarin Pharmaceutical Inc.: JP Morgan cuts target price to $86 from $87
BMRN•JP Morgan cut its target price for BioMarin Pharmaceutical to $86 from $87.
Related News
Gold rises as dollar weakens; Democrats score early wins in US midterm elections
GLD•
Canaccord Genuity raises Ceribell target price to $33 from $26
CBLL•
Sands China publishes listing document for $1 billion senior debt offering
LVS•
ADM: JP Morgan raises to neutral from underweight
ADM•
Piper Sandler raises Keurig Dr Pepper target price to $41 from $38
KDP•